Evidence map›Paper›PMID 19496742›Full record

ReviewCritical reviews in immunology2009

Integrin function in T-cell homing to lymphoid and nonlymphoid sites: getting there and staying there.

Christopher C Denucci, Jason S Mitchell, Yoji Shimizu

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Critical reviews in immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02721719 (The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis), which is not on this map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02721719 unknown statusnot on this mapstarted 2016, after this paper: background citation

The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis

TypeobservationalSponsorUniversity of British ColumbiaRan2016 to 2024Enrolled50ConditionsUlcerative Colitis
3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 132 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Human Blood IgAEuropean journal of immunology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Targeting integrin pathways: mechanisms and advances in therapy.Signal transduction and targeted therapy · 2023
    Review
  12. Integrin-Mediated Exosomal Homing to Organs.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christopher C DenucciDepartment of Laboratory Medicine and Pathology, Center for Immunology, Masonic Cancer Center, University of Minnesota Medical School, Minneapolis, MN, USA.
Jason S Mitchell
Yoji Shimizu
University of Minnesota Medical Center · US

Funding

TRAINING GRANT IN MICROBIOLOGY/CANCER RESEARCHT32CA009138 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Scott M. Dehm · 1985 to 2026
$11.3M
STRUCTURE/FUNCTION ANALYSIS OF T CELL BETA1 INTEGRINR01AI038474 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SHIMIZU, YOJI · 1995 to 2014
$4.7M
Very Late Antigen Integrin Activity on T CellsR01AI031126 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SHIMIZU, YOJI · 1996 to 2010
$3.7M
Pl 3-kinase gamma &T cell-mediated anti-viral responsesR01AI064271 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SHIMIZU, YOJI · 2005 to 2009
$1.2M
Adapter proteins and integrin functionR56AI038474 · NIAID · UNIVERSITY OF MINNESOTA · PI SHIMIZU, YOJI · 2010 to 2010
$108k
The role of beta1 integrin in modulating gut-homing alpha4beta7 on T cellsF30DK082139 · NIDDK · UNIVERSITY OF MINNESOTA · PI DENUCCI, CHRISTOPHER CHARLES · 2008 to 2010
$99k
REGULATION OF VLA INTEGRIN FUNCTION ON T-CELLSR29AI031126 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SHIMIZU, YOJI · 1991 to 1995
–
NCI NIH HHS T32 CA009138NIAID NIH HHS AI031126NIAID NIH HHS AI038474NIAID NIH HHS AI064271NIAID NIH HHS R01 AI031126NIAID NIH HHS R01 AI038474NIAID NIH HHS R01 AI064271NIAID NIH HHS R56 AI038474NIDDK NIH HHS F30 DK082139NIDDK NIH HHS F30DK082139
6 · The paper itself

Abstract

The continuous recirculation of naive T cells and their subsequent migration to tissue following activation is crucial for maintaining protective immunity against invading pathogens. The preferential targeting of effector and memory T cells to tissue is instructed during priming and mediated by cell surface expressed adhesion receptors such as integrins. Integrins arc involved in nearly all aspects of T-cell life, including naive T-cell circulation, activation, and finally effector T-cell trafficking and localization. Recent research has revealed that microenvironmental factors present during T-cell priming result in the specific regulation of adhesion/integrin and chemokine receptor expression. Once antigen-experienced T cells enter tissue, further changes in integrin expression may occur that arc critical for T-cell localization, retention, effector function, and survival. This review discusses the function of integrin expression on T cells and the multiple roles integrins play on naive T cells and in directing effector T-cell trafficking to nonlymphoid sites in order to maintain protective adaptive immunity at body barriers.

Indexed as

AnimalsCell AdhesionCell MovementCytokinesDendritic CellsHumansImmunological SynapsesIntegrinsIntercellular Adhesion Molecule-1Lymph NodesLymphocyte ActivationReceptors, ChemokineT-LymphocytesVascular Cell Adhesion Molecule-1CytokinesIntegrinsIntercellular Adhesion Molecule-1Receptors, ChemokineVascular Cell Adhesion Molecule-1

Identifiers

PMID19496742
PMCPMC2744463
OpenAlexW1998515468

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.